Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03970720 · ClinicalTrials.gov registry record · Phase 2
Restoration of Hypoglycemia Awareness With Metoclopramide
A Phase 2 study of Hypoglycemia Unawareness, sponsored by Simon Fisher.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 36
- Enrollment target
- 2
- Study locations
NCT03970720 is a Phase 2 study of Hypoglycemia Unawareness that is actively recruiting participants, run by Simon Fisher. The registered enrollment target is 36 participants, above the 12-participant average among 3 other Hypoglycemia Unawareness trials with a reported enrollment target (200% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT03970720, a Phase 2 study of Hypoglycemia Unawareness, is actively recruiting participants, sponsored by Simon Fisher.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 36 participants
- Enrollment target
- 2
- Study locations
Study Summary
Metoclopramide is a drug approved by the FDA for gastroesophageal reflux and to relieve symptoms in adults with acute and recurrent diabetic gastroparesis. The objective of this study is to determine whether metoclopramide can improve hypoglycemia awareness and decrease the incidence of hypoglycemia in type 1 diabetes patients with hypoglycemia unawareness.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Metoclopramide
Study Locations (2)
Kentucky
- University of Kentucky - Lexington
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2019-05-28 |
| Est. Completion | 2027-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03970720
The ClinicalTrials.gov registry entry for NCT03970720 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 12-participant average among 3 other Hypoglycemia Unawareness trials with a reported enrollment target (200% higher). The listed sponsor is Simon Fisher, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypoglycemia Unawareness appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03970720 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Kentucky, Utah.
Frequently Asked Questions
What is clinical trial NCT03970720 about?
NCT03970720 is a clinical study titled "Restoration of Hypoglycemia Awareness With Metoclopramide". Metoclopramide is a drug approved by the FDA for gastroesophageal reflux and to relieve symptoms in adults with acute and recurrent diabetic gastroparesis. The objective of this study is to determine whether metoclopramide can improve hypoglycemia awareness and decrease the incidence of hypoglycemia...
What is the current status of trial NCT03970720?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 36 participants. The study started on 2019-05-28. Estimated completion is 2027-12-31.
What conditions does trial NCT03970720 study?
This clinical trial studies the following conditions: Hypoglycemia Unawareness.
What interventions are being tested in trial NCT03970720?
The interventions under investigation include: Placebo (DRUG), Metoclopramide (DRUG).
Who is sponsoring clinical trial NCT03970720?
This trial is sponsored by Simon Fisher, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03970720 being conducted?
This trial has 2 study locations across Kentucky, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypoglycemia Unawareness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.